Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q1 EPS by 3c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.30), $0.03 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• Amneal gets FDA approval for lanreotide injection, launches immediately